Authors:
Lygidakis, NJ
Vlachos, L
Raptis, S
Rassidakis, G
Kittas, C
Citation: Nj. Lygidakis et al., C: Locoregional targeting immunochemotherapy for resectable and unresectable pancreatic head carcinoma: The Athens experience, MD AND SOIL, 2002, pp. 280-285
Authors:
Lygidakis, NJ
Sgourakis, G
Dedemadi, G
Safioleus, MC
Nestoridis, J
Citation: Nj. Lygidakis et al., Regional chemoimmunotherapy for nonresectable metastatic liver disease of colorectal origin. A prospective randomized study, HEP-GASTRO, 48(40), 2001, pp. 1085-1087
Authors:
Schietroma, M
Carlei, F
Lezoche, E
Agnifili, A
Enang, GN
Mattucci, S
Minervini, S
Lygidakis, NJ
Citation: M. Schietroma et al., Evaluation of immune response in patients after open or laparoscopic cholecystectomy, HEP-GASTRO, 48(39), 2001, pp. 642-646
Authors:
Lygidakis, NJ
Sgourakis, GJ
Dedemadi, GV
Vlachos, L
Safioleas, M
Citation: Nj. Lygidakis et al., Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience, HEP-GASTRO, 48(37), 2001, pp. 95-101
Authors:
Lygidakis, NJ
Sgourakis, G
Dedemadi, G
Spentzouris, N
Kontis, A
Nestoridis, J
Citation: Nj. Lygidakis et al., Preoperative main portal branch transection combined with liver locoregional transarterial neo and adjuvant immunochemotherapy for patients with hepatocellular carcinoma, HEP-GASTRO, 47(36), 2000, pp. 1546-1554
Citation: J. Kountouras et al., Omeprazole and regulation of cytokine profile in Helicobacter pylori-infected patients with duodenal ulcer disease, HEP-GASTRO, 47(35), 2000, pp. 1301-1304
Authors:
Lygidakis, NJ
Vlachos, L
Raptis, S
Rassidakis, G
Balaskas, G
Sgourakis, G
Mourikis, D
Kehagias, D
Kittas, C
Citation: Nj. Lygidakis et al., New frontiers in liver surgery. Two-stage liver surgery for the managementof advanced metastatic liver disease, HEP-GASTRO, 46(28), 1999, pp. 2216-2228
Authors:
Lygidakis, NJ
Vlachos, L
Raptis, S
Sgourakis, G
Mourikis, D
Kehagias, D
Citation: Nj. Lygidakis et al., Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma, HEP-GASTRO, 46(28), 1999, pp. 2229-2239
Citation: Nj. Lygidakis et al., Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regionalchemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial, HEP-GASTRO, 46(27), 1999, pp. 2035-2038
Authors:
Lygidakis, NJ
Safioleas, M
Sgourakis, G
Aphinives, P
Citation: Nj. Lygidakis et al., Stop-flow thoracic perfusion for unresectable pulmonary carcinoma with or without inhalation IL-2 immunotherapy. A prospective randomized study, HEP-GASTRO, 46(26), 1999, pp. 792-798
Authors:
Boura, P
Kountouras, J
Lygidakis, NJ
Safioleas, M
Aphinives, P
Citation: P. Boura et al., Transplenic and transtumoral in vivo immunostimulation: Effect on cellularimmunity parameters, HEP-GASTRO, 46(26), 1999, pp. 799-803
Authors:
Lygidakis, NJ
Safioleas, M
Sgourakis, G
Spentzouris, N
Dedemadi, G
Sotiropoulou, P
Citation: Nj. Lygidakis et al., Metastatic melanoma: Transplenic immunostimulation - A new therapeutical alternative for an ever-challenging disease, HEP-GASTRO, 46(25), 1999, pp. 148-156